Leendert Hj Looijenga

41PUBLICATIONS
96CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 27, 2026
Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

|Apr 17, 2026
Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes.

|Feb 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Milena Urbini, Thomas F Eleveld, Maurizio Polano

|Jul 12, 2025
Yolk Sac Elements in Tumors Derived from Pluripotent Stem Cells: Borrowing Knowledge from Human Germ Cell Tumors.

Marnix van Soest, Joaquin Montilla-Rojo, Thomas F Eleveld

|Apr 15, 2025
Chromosome-specific aberrations, rather than general aneuploidy, may drive mouse embryonic stem cell-derived teratoma metastasis.

Joaquin Montilla-Rojo, Sanne Hillenius, Thomas F Eleveld

|Nov 25, 2024
Non-alkylating agents-induced gonadotoxicity in pre-pubertal males: Insights on the clinical and pre-clinical front.

Sruthi Sriram, Tiago Macedo, Annelies Mavinkurve-Groothuis

Pageof 7

Frequent Collaborators

11 joint publications

João Lobo

8 joint publications

Carmen Jerónimo

8 joint publications

Rui Henrique

6 joint publications

Annelies Mavinkurve-Groothuis